Just catching up on this thread, well done to you guys, it appears many of you had seen this playing out.
I spotlighted them in my newsletter this week (link here)
With one state being a $20M opportunity alone, it seems there's still a lot of upside despite the recent 200% rally.
My question to you guys is: has someone done the work on competition? Is the CEO right that there's actually zero competitors?
My quick spike returned nothing so that may well be true, but I imagine there might be other alternatives somewhere out there...
Ann: ImpediMed Achieves Critical Mass in First Key Target State, page-18
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
-0.002(3.28%) |
Mkt cap ! $119.3M | |||
| Open | High | Low | Value | Volume |
| 6.2¢ | 6.3¢ | 5.9¢ | $50.81K | 833.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 250506 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 121721 | 2 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IPD (ASX) Chart |